EARNINGS AND TRADING: Blencowe updates Orom-Cross net present value
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
| Price | 79.00p on 29-05-2026 at 16:45:08 |
|---|---|
| Change | 3.50p 4.64% |
| Buy | 80.00p |
| Sell | 78.00p |
| Last Trade: | Sell 3,000.00 at 78.70p |
| Day's Volume: | 1,078,204 |
| Last Close: | 79.00p |
| Open: | 76.00p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 79.00p - 79.00p |
| 52wk Range: | 28.50p - 90.50p |
| Market Capitalisation: | £359.54m |
| VWAP: | 78.09281p |
| Shares in Issue: | 455.11m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 3,000 | 78.70p | Ordinary |
16:29:14 - 29-May-26 |
| Sell* | 2,000 | 78.70p | Ordinary |
16:26:32 - 29-May-26 |
| Sell* | 1,700 | 78.70p | Ordinary |
16:24:57 - 29-May-26 |
| Buy* | 2,000 | 79.20p | Ordinary |
16:15:32 - 29-May-26 |
| Sell* | 1,260 | 78.78p | Ordinary |
16:15:19 - 29-May-26 |
| Sell* | 12,000 | 78.25p | Ordinary |
16:15:19 - 29-May-26 |
| Sell* | 4,000 | 78.6653p | Ordinary |
16:13:53 - 29-May-26 |
| Sell* | 405 | 78.76p | Ordinary |
16:12:59 - 29-May-26 |
| Sell* | 1,261 | 78.6961p | Ordinary |
16:06:54 - 29-May-26 |
| Sell* | 19,059 | 78.70p | Ordinary |
16:06:40 - 29-May-26 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 19th May 2026 7:00 am | RNS | Unaudited Preliminary Full Year 2025 Results |
| 13th May 2026 7:00 am | RNS | Notice of Preliminary Results and Presentation |
| 13th May 2026 7:00 am | RNS | Issue of Equity and Total Voting Rights |
| 6th May 2026 7:00 am | RNS | Pre|CISION® payload release vs approved ADCs |
| 28th Apr 2026 7:00 am | RNS | Block Listing Six Monthly Return |
| 21st Apr 2026 7:00 am | RNS | Avacta data AACR underline AVA6103 profile |
| 14th Apr 2026 11:37 am | RNS-R | Christina Coughlin - In Vivo 2026 Rising Leader |
| 9th Apr 2026 7:00 am | RNS | Q1 2026 Business Update |
| 8th Apr 2026 7:00 am | RNS-R | Avacta Announces Science Day 2026 |
| 31st Mar 2026 7:00 am | RNS | First patient treated in Phase 1 trial of AVA6103 |